Analystreport

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Nomura to $86.00. They now have a "sell" rating on the stock.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview